Bayforest Capital »

Protagonist Therapeutics shares owned by Bayforest Capital

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Bayforest Capital from 13F filings

Historical chart of Bayforest Capital investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Bayforest Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Bayforest Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $328k 2.7k 122.58

More positions owned by Bayforest Capital

Slide Ins Hldgs (SLDE)
Alexandria Real Estate Equities (ARE)
Perimeter Solutions Common Stock (PRM)
NetApp (NTAP)
Talos Energy (TALO)
Asbury Automotive (ABG)
C3 Ai Cl A (AI)
Solaredge Technologies (SEDG)
Hinge Health Cl A (HNGE)
Millrose Pptys Com Cl A (MRP)
Chord Energy Corporation Com New (CHRD)
A Mark Precious Metals (GOLD)
Bandwidth Com Cl A (BAND)
Perrigo SHS (PRGO)
Northern Oil And Gas Inc Mn (NOG)

View all positions for Bayforest Capital

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Portfolio Management
Wellington Management Company
UBS Group
State Street Corporation
Henderson Group
Vanguard Capital Management
Johnson & Johnson
Invesco
Jupiter Topco
Geode Capital Management
T. Rowe Price Associates
Woodline Partners

View all funds holding Protagonist Therapeutics